Skip to content
To the full analysis

Genmab stock: balance sheet and debt

GMAB.CO
$523.26Closing price of 12 Nov 2026MEQIRI Score 66 out of 100

Genmab has a debt to equity ratio of 0.95 and an interest coverage of 20.5x.

Daily figure as of 13 Nov 2026

Debt / Equity
0.95
Interest coverage
20.5x
Current ratio
2.02
Cash & equivalents
$1.71B
Total assets
$12.84B
Equity ratio
45.4%
Goodwill
$354.23M
Plus intangible assets of $9.1B
Net debt
$3.84B

Total assets and equity ratio

How large the balance sheet of Genmab A/S is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2006$1.8Bnot reported separatelynot reported separately89.1%−$1.71B
2007$3.96Bnot reported separatelynot reported separately72.8%−$3.68B
2008$3.26B$313.83M$313.83M67.2%−$1.75B
2009$2.22Bnot reported separatelynot reported separately58.4%−$1.25B
2010$2.48Bnot reported separatelynot reported separately43.5%−$1.52B
2011$1.56Bnot reported separatelynot reported separately31.1%−$1.09B
2012$1.69Bnot reported separatelynot reported separately22.6%−$1.5B
2013$1.73B$2.54Mnot split out38.1%−$1.55B
2014$2.87B$62.53Mnot split out70.9%−$2.66B
2015$3.9B$192.64Mnot split out89.3%−$3.49B
2016$5.24B$181.9Mnot split out92.1%−$3.92B
2017$6.6B$124.4Mnot split out95.0%−$5.42B
2018$8.46B$470.36Mnot split out94.7%−$6.11B
2019$15.14B$470Mnot split out92.8%−$10.79B
2020$21.14B$338Mnot split out90.4%−$15.76B
2021$24.63B$254Mnot split out90.1%−$18.91B
2022$30.12B$146Mnot split out90.6%−$21.73B
2023$35.29B$101Mnot split out89.6%−$27.37B
2024$45.81B$14.88B$2.54B80.1%−$20.07B
2025$12.84B$9.46B$354.23M45.4%$3.84B

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt. In years without separate goodwill, the table shows the sum of goodwill and intangible assets, because the data do not list goodwill separately there.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2006$1.72B$1.61B$18.21M0.01
2007$3.69B$2.88B$15.67M0.01
2008$1.76B$2.19B$14.7M0.01
2009$1.28B$1.3B$24.94M0.02
2010$1.65B$1.08B$133.72M0.12
2011$1.1B$486.42M$11.85M0.02
2012$1.5B$383.19M$5.66M0.01
2013$1.56B$659.52M$2.49M0
2014$2.66B$2.03B$355K0
2015$3.49B$3.49B$118K0
2016$3.92B$4.83B$00
2017$5.42B$6.27B$00
2018$6.11B$8.01B$00
2019$10.97B$14.05B$181M0.01
2020$16.08B$19.12B$319M0.02
2021$19.34B$22.2B$425M0.02
2022$22.32B$27.28B$597M0.02
2023$28.14B$31.61B$770M0.02
2024$21.1B$36.7B$1.03B0.03
2025$1.71B$5.83B$5.55B0.95

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = DKK 6.7461)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 24 Apr 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy